{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T02:39:25Z","timestamp":1767839965669,"version":"3.49.0"},"reference-count":172,"publisher":"Elsevier BV","issue":"49","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.vaccine.2010.09.012","type":"journal-article","created":{"date-parts":[[2010,10,7]],"date-time":"2010-10-07T08:26:18Z","timestamp":1286439978000},"page":"7810-7823","source":"Crossref","is-referenced-by-count":11,"title":["Prion protein self-interactions: A gateway to novel therapeutic strategies?"],"prefix":"10.1016","volume":"28","author":[{"given":"Alan","family":"Rigter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan P.M.","family":"Langeveld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred G.","family":"van Zijderveld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Bossers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"105","key":"10.1016\/j.vaccine.2010.09.012_bib0005","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/2151043a0","article-title":"Self-replication and scrapie","volume":"215","author":"Griffith","year":"1967","journal-title":"Nature"},{"issue":"4542","key":"10.1016\/j.vaccine.2010.09.012_bib0010","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1126\/science.6801762","article-title":"Novel proteinaceous infectious particles cause scrapie","volume":"216","author":"Prusiner","year":"1982","journal-title":"Science"},{"issue":"9006","key":"10.1016\/j.vaccine.2010.09.012_bib0015","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0140-6736(96)91412-9","article-title":"A new variant of Creutzfeldt\u2013Jakob disease in the UK","volume":"347","author":"Will","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2010.09.012_bib0020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/bmb\/66.1.71","article-title":"Trafficking, turnover and membrane topology of PrP","volume":"66","author":"Harris","year":"2003","journal-title":"Br Med Bull"},{"issue":"3","key":"10.1016\/j.vaccine.2010.09.012_bib0025","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1128\/CMR.12.3.429","article-title":"Cellular biology of prion diseases","volume":"12","author":"Harris","year":"1999","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"10.1016\/j.vaccine.2010.09.012_bib0030","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1073\/pnas.94.6.2333","article-title":"COOH-terminal sequence of the cellular prion protein directs subcellular trafficking and controls conversion into the scrapie isoform","volume":"94","author":"Kaneko","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6763","key":"10.1016\/j.vaccine.2010.09.012_bib0035","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/45574","article-title":"Transmissible and genetic prion diseases share a common pathway of neurodegeneration","volume":"402","author":"Hegde","year":"1999","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.vaccine.2010.09.012_bib0040","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1128\/MCB.26.7.2697-2715.2006","article-title":"Cell-specific metabolism and pathogenesis of transmembrane prion protein","volume":"26","author":"Gu","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.vaccine.2010.09.012_bib0045","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/bmb\/66.1.21","article-title":"Biochemistry and structure of PrP(C) and PrP(Sc)","volume":"66","author":"Riesner","year":"2003","journal-title":"Br Med Bull"},{"key":"10.1016\/j.vaccine.2010.09.012_bib0050","first-page":"57","article-title":"Pathogenesis of natural scrapie in sheep","volume":"16","author":"van Keulen","year":"2000","journal-title":"Arch Virol Suppl"},{"issue":"10","key":"10.1016\/j.vaccine.2010.09.012_bib0055","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/nrd1525","article-title":"Prion diseases\u2014close to effective therapy?","volume":"3","author":"Cashman","year":"2004","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"10.1016\/j.vaccine.2010.09.012_bib0060","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1051\/vetres:2007061","article-title":"TSE pathogenesis in cattle and sheep","volume":"39","author":"van Keulen","year":"2008","journal-title":"Vet Res"},{"issue":"3","key":"10.1016\/j.vaccine.2010.09.012_bib0065","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00705-007-0007-4","article-title":"Pathogenesis of bovine spongiform encephalopathy in sheep","volume":"153","author":"van Keulen","year":"2008","journal-title":"Arch Virol"},{"issue":"Pt 10","key":"10.1016\/j.vaccine.2010.09.012_bib0070","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1099\/0022-1317-76-10-2583","article-title":"A cellular form of prion protein (PrPC) exists in many non-neuronal tissues of sheep","volume":"76","author":"Horiuchi","year":"1995","journal-title":"J Gen Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2010.09.012_bib0075","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.tibs.2007.11.003","article-title":"Intriguing nucleic-acid-binding features of mammalian prion protein","volume":"33","author":"Silva","year":"2008","journal-title":"Trends Biochem Sci"},{"issue":"12","key":"10.1016\/j.vaccine.2010.09.012_bib0080","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/nm1297-1383","article-title":"The human 37-kDa laminin receptor precursor interacts with the prion protein in eukaryotic cells","volume":"3","author":"Rieger","year":"1997","journal-title":"Nat Med"},{"issue":"21","key":"10.1016\/j.vaccine.2010.09.012_bib0085","doi-asserted-by":"crossref","first-page":"5863","DOI":"10.1093\/emboj\/20.21.5863","article-title":"The 37-kDa\/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein","volume":"20","author":"Gauczynski","year":"2001","journal-title":"EMBO J"},{"issue":"5","key":"10.1016\/j.vaccine.2010.09.012_bib0090","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1086\/505914","article-title":"The 37-kDa\/67-kDa laminin receptor acts as a receptor for infectious prions and is inhibited by polysulfated glycanes","volume":"194","author":"Gauczynski","year":"2006","journal-title":"J Infect Dis"},{"issue":"21","key":"10.1016\/j.vaccine.2010.09.012_bib0095","doi-asserted-by":"crossref","first-page":"5876","DOI":"10.1093\/emboj\/20.21.5876","article-title":"Identification of interaction domains of the prion protein with its 37-kDa\/67-kDa laminin receptor","volume":"20","author":"Hundt","year":"2001","journal-title":"EMBO J"},{"issue":"24","key":"10.1016\/j.vaccine.2010.09.012_bib0100","doi-asserted-by":"crossref","first-page":"14793","DOI":"10.1074\/jbc.270.24.14793","article-title":"The N-terminal domain of a glycolipid-anchored prion protein is essential for its endocytosis via clathrin-coated pits","volume":"270","author":"Shyng","year":"1995","journal-title":"J Biol Chem"},{"issue":"14","key":"10.1016\/j.vaccine.2010.09.012_bib0105","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1093\/emboj\/cdg344","article-title":"The mechanism of internalization of glycosylphosphatidylinositol-anchored prion protein","volume":"22","author":"Sunyach","year":"2003","journal-title":"EMBO J"},{"issue":"Pt 21","key":"10.1016\/j.vaccine.2010.09.012_bib0110","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1242\/jcs.02627","article-title":"Assigning functions to distinct regions of the N-terminus of the prion protein that are involved in its copper-stimulated, clathrin-dependent endocytosis","volume":"118","author":"Taylor","year":"2005","journal-title":"J Cell Sci"},{"issue":"1","key":"10.1016\/j.vaccine.2010.09.012_bib0115","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1042\/BJ20061736","article-title":"The low-density lipoprotein receptor-related protein 1 (LRP1) mediates the endocytosis of the cellular prion protein","volume":"402","author":"Taylor","year":"2007","journal-title":"Biochem J"},{"issue":"Pt 6","key":"10.1016\/j.vaccine.2010.09.012_bib0120","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1242\/jcs.021816","article-title":"LRP1 controls biosynthetic and endocytic trafficking of neuronal prion protein","volume":"121","author":"Parkyn","year":"2008","journal-title":"J Cell Sci"},{"issue":"1","key":"10.1016\/j.vaccine.2010.09.012_bib0125","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00109-004-0605-5","article-title":"Cellular prion protein neuroprotective function: implications in prion diseases","volume":"83","author":"Roucou","year":"2005","journal-title":"J Mol Med"},{"issue":"17","key":"10.1016\/j.vaccine.2010.09.012_bib0130","doi-asserted-by":"crossref","first-page":"17430","DOI":"10.1074\/jbc.C500058200","article-title":"Mammalian prion protein suppresses Bax-induced cell death in yeast","volume":"280","author":"Li","year":"2005","journal-title":"J Biol Chem"},{"issue":"13","key":"10.1016\/j.vaccine.2010.09.012_bib0135","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1093\/emboj\/cdf325","article-title":"Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection","volume":"21","author":"Zanata","year":"2002","journal-title":"EMBO J"},{"issue":"49","key":"10.1016\/j.vaccine.2010.09.012_bib0140","doi-asserted-by":"crossref","first-page":"11330","DOI":"10.1523\/JNEUROSCI.2313-05.2005","article-title":"Interaction of cellular prion and stress-inducible protein 1 promotes neuritogenesis and neuroprotection by distinct signaling pathways","volume":"25","author":"Lopes","year":"2005","journal-title":"J Neurosci"},{"issue":"26","key":"10.1016\/j.vaccine.2010.09.012_bib0145","doi-asserted-by":"crossref","first-page":"6691","DOI":"10.1523\/JNEUROSCI.1701-08.2008","article-title":"Endocytosis of prion protein is required for ERK1\/2 signaling induced by stress-inducible protein 1","volume":"28","author":"Caetano","year":"2008","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.vaccine.2010.09.012_bib0150","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.nbd.2007.01.005","article-title":"Short-term memory formation and long-term memory consolidation are enhanced by cellular prion association to stress-inducible protein 1","volume":"26","author":"Coitinho","year":"2007","journal-title":"Neurobiol Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2010.09.012_bib0155","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1161\/01.STR.0000217262.03192.d4","article-title":"Deletion of cellular prion protein results in reduced Akt activation, enhanced postischemic caspase-3 activation, and exacerbation of ischemic brain injury","volume":"37","author":"Weise","year":"2006","journal-title":"Stroke"},{"issue":"10","key":"10.1016\/j.vaccine.2010.09.012_bib0160","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1097\/00001756-200307180-00019","article-title":"Cellular prion protein ablation impairs behavior as a function of age","volume":"14","author":"Coitinho","year":"2003","journal-title":"Neuroreport"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2010.09.012_bib0165","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.nbd.2005.01.001","article-title":"Mice devoid of prion protein have cognitive deficits that are rescued by reconstitution of PrP in neurons","volume":"19","author":"Criado","year":"2005","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.vaccine.2010.09.012_bib0170","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1196\/annals.1397.076","article-title":"Cellular prion protein signaling in serotonergic neuronal cells","volume":"1096","author":"Mouillet-Richard","year":"2007","journal-title":"Ann N Y Acad Sci"},{"issue":"1\u20133","key":"10.1016\/j.vaccine.2010.09.012_bib0175","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0014-5793(04)00029-8","article-title":"Prion protein is a component of the multimolecular signaling complex involved in T cell activation","volume":"560","author":"Mattei","year":"2004","journal-title":"FEBS Lett"},{"issue":"2","key":"10.1016\/j.vaccine.2010.09.012_bib0180","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1083\/jcb.200409127","article-title":"Prion protein recruits its neuronal receptor NCAM to lipid rafts to activate p59fyn and to enhance neurite outgrowth","volume":"169","author":"Santuccione","year":"2005","journal-title":"J Cell Biol"},{"issue":"3","key":"10.1016\/j.vaccine.2010.09.012_bib0185","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0014-5793(00)02070-6","article-title":"Laminin-induced PC-12 cell differentiation is inhibited following laser inactivation of cellular prion protein","volume":"482","author":"Graner","year":"2000","journal-title":"FEBS Lett"},{"issue":"1","key":"10.1016\/j.vaccine.2010.09.012_bib0865","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2990.2008.00947.x","article-title":"Protein microarray analysis identifies human cellular prion protein interactors","volume":"35","author":"Satoh","year":"2009","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"9","key":"10.1016\/j.vaccine.2010.09.012_bib0195","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/cr.2009.86","article-title":"PrPC-related signal transduction is influenced by copper, membrane integrity and the alpha cleavage site","volume":"19","author":"Haigh","year":"2009","journal-title":"Cell Res"},{"issue":"7","key":"10.1016\/j.vaccine.2010.09.012_bib0200","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1073\/pnas.0712036105","article-title":"Mechanisms of prion protein assembly into amyloid","volume":"105","author":"Stohr","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"10.1016\/j.vaccine.2010.09.012_bib0205","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/1074-5521(95)90087-X","article-title":"Aggregates of scrapie-associated prion protein induce the cell-free conversion of protease-sensitive prion protein to the protease-resistant state","volume":"2","author":"Caughey","year":"1995","journal-title":"Chem Biol"},{"issue":"6","key":"10.1016\/j.vaccine.2010.09.012_bib0210","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1073\/pnas.052703499","article-title":"Structural studies of the scrapie prion protein by electron crystallography","volume":"99","author":"Wille","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"22","key":"10.1016\/j.vaccine.2010.09.012_bib0215","doi-asserted-by":"crossref","first-page":"8342","DOI":"10.1073\/pnas.0402254101","article-title":"Evidence for assembly of prions with left-handed beta-helices into trimers","volume":"101","author":"Govaerts","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.vaccine.2010.09.012_bib0220","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jmb.2006.05.042","article-title":"Two-rung model of a left-handed beta-helix for prions explains species barrier and strain variation in transmissible spongiform encephalopathies","volume":"360","author":"Langedijk","year":"2006","journal-title":"J Mol Biol"},{"issue":"6","key":"10.1016\/j.vaccine.2010.09.012_bib0225","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/j.1742-4658.2008.06293.x","article-title":"The elusive intermediate on the folding pathway of the prion protein","volume":"275","author":"Jenkins","year":"2008","journal-title":"FEBS J"},{"issue":"33","key":"10.1016\/j.vaccine.2010.09.012_bib0870","doi-asserted-by":"crossref","first-page":"21981","DOI":"10.1074\/jbc.M809173200","article-title":"Conformational properties of beta-PrP","volume":"284","author":"Hosszu","year":"2009","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/j.vaccine.2010.09.012_bib0235","doi-asserted-by":"crossref","first-page":"6300","DOI":"10.1074\/jbc.M608926200","article-title":"Oligomerization of the human prion protein proceeds via a molten globule intermediate","volume":"282","author":"Gerber","year":"2007","journal-title":"J Biol Chem"},{"issue":"35","key":"10.1016\/j.vaccine.2010.09.012_bib0240","doi-asserted-by":"crossref","first-page":"11673","DOI":"10.1021\/ja063880b","article-title":"Early intermediate in human prion protein folding as evidenced by ultrarapid mixing experiments","volume":"128","author":"Apetri","year":"2006","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.vaccine.2010.09.012_bib0245","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0076-6879(06)12002-9","article-title":"Fractionation of prion protein aggregates by asymmetrical flow field-flow fractionation","volume":"412","author":"Silveira","year":"2006","journal-title":"Methods Enzymol"},{"issue":"6489","key":"10.1016\/j.vaccine.2010.09.012_bib0250","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/370471a0","article-title":"Cell-free formation of protease-resistant prion protein","volume":"370","author":"Kocisko","year":"1994","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.vaccine.2010.09.012_bib0255","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0968-0004(01)01792-3","article-title":"Interactions between prion protein isoforms: the kiss of death?","volume":"26","author":"Caughey","year":"2001","journal-title":"Trends Biochem Sci"},{"issue":"17","key":"10.1016\/j.vaccine.2010.09.012_bib0260","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1093\/emboj\/19.17.4425","article-title":"Evidence of a molecular barrier limiting susceptibility of humans, cattle and sheep to chronic wasting disease","volume":"19","author":"Raymond","year":"2000","journal-title":"EMBO J"},{"issue":"6","key":"10.1016\/j.vaccine.2010.09.012_bib0265","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s00109-004-0534-3","article-title":"Prion protein conversion in vitro","volume":"82","author":"Supattapone","year":"2004","journal-title":"J Mol Med"},{"issue":"19","key":"10.1016\/j.vaccine.2010.09.012_bib0875","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1038\/emboj.2008.181","article-title":"Cell-free propagation of prion strains","volume":"27","author":"Castilla","year":"2008","journal-title":"EMBO J"},{"issue":"4","key":"10.1016\/j.vaccine.2010.09.012_bib0275","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.vetmic.2007.04.004","article-title":"Generation of genuine prion infectivity by serial PMCA","volume":"123","author":"Weber","year":"2007","journal-title":"Vet Microbiol"},{"issue":"23","key":"10.1016\/j.vaccine.2010.09.012_bib0280","doi-asserted-by":"crossref","first-page":"9741","DOI":"10.1073\/pnas.0702662104","article-title":"Formation of native prions from minimal components in vitro","volume":"104","author":"Deleault","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"24","key":"10.1016\/j.vaccine.2010.09.012_bib0285","doi-asserted-by":"crossref","first-page":"21140","DOI":"10.1074\/jbc.M111402200","article-title":"Pathway complexity of prion protein assembly into amyloid","volume":"277","author":"Baskakov","year":"2002","journal-title":"J Biol Chem"},{"issue":"44","key":"10.1016\/j.vaccine.2010.09.012_bib0290","doi-asserted-by":"crossref","first-page":"13390","DOI":"10.1021\/bi011111t","article-title":"Isolation of isoforms of mouse prion protein with PrP(SC)-like structural properties","volume":"40","author":"Lu","year":"2001","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.vaccine.2010.09.012_bib0295","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1128\/JVI.74.3.1407-1414.2000","article-title":"Susceptibility of sheep for scrapie as assessed by in vitro conversion of nine naturally occurring variants of PrP","volume":"74","author":"Bossers","year":"2000","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2010.09.012_bib0300","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1631-0691(02)01465-8","article-title":"Multiplicative genetic effects in scrapie disease susceptibility","volume":"325","author":"Dubois","year":"2002","journal-title":"C R Biol"},{"issue":"4","key":"10.1016\/j.vaccine.2010.09.012_bib0305","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1128\/JVI.77.4.2696-2700.2003","article-title":"PrP polymorphisms tightly control sheep prion replication in cultured cells","volume":"77","author":"Sabuncu","year":"2003","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2010.09.012_bib0310","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1034\/j.1600-0463.2002.100105.x","article-title":"Influence of the prion protein gene Prnp, on scrapie susceptibility in sheep","volume":"110","author":"Tranulis","year":"2002","journal-title":"Apmis"},{"issue":"Pt 9","key":"10.1016\/j.vaccine.2010.09.012_bib0315","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1099\/vir.0.80901-0","article-title":"Sheep scrapie susceptibility-linked polymorphisms do not modulate the initial binding of cellular to disease-associated prion protein prior to conversion","volume":"86","author":"Rigter","year":"2005","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2010.09.012_bib0320","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2091-8-6","article-title":"Mapping of possible prion protein self-interaction domains using peptide arrays","volume":"8","author":"Rigter","year":"2007","journal-title":"BMC Biochem"},{"key":"10.1016\/j.vaccine.2010.09.012_bib0325","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2091-10-29","article-title":"Prion protein self-peptides modulate prion interactions and conversion","volume":"10","author":"Rigter","year":"2009","journal-title":"BMC Biochem"},{"issue":"6","key":"10.1016\/j.vaccine.2010.09.012_bib0330","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1128\/JCM.00160-07","article-title":"Molecular discrimination of atypical bovine spongiform encephalopathy strains from a geographical region spanning a wide area in Europe","volume":"45","author":"Jacobs","year":"2007","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2010.09.012_bib0335","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1128\/JCM.42.3.972-980.2004","article-title":"Discrimination between scrapie and bovine spongiform encephalopathy in sheep by molecular size, immunoreactivity, and glycoprofile of prion protein","volume":"42","author":"Thuring","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"28","key":"10.1016\/j.vaccine.2010.09.012_bib0340","doi-asserted-by":"crossref","first-page":"10404","DOI":"10.1073\/pnas.0403522101","article-title":"Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPSc","volume":"101","author":"Moroncini","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.vaccine.2010.09.012_bib0880","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0014-5793(97)00920-4","article-title":"NMR characterization of the full-length recombinant murine prion protein, mPrP(23\u2013231)","volume":"413","author":"Riek","year":"1997","journal-title":"FEBS Lett"},{"issue":"10","key":"10.1016\/j.vaccine.2010.09.012_bib0350","doi-asserted-by":"crossref","first-page":"7465","DOI":"10.1074\/jbc.M610051200","article-title":"Toward molecular dissection of PrPC\u2013PrPSc interactions","volume":"282","author":"Solforosi","year":"2007","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/j.vaccine.2010.09.012_bib0355","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1021\/ar050226c","article-title":"The emerging principles of Mammalian prion propagation and transmissibility barriers: insight from studies in vitro","volume":"39","author":"Surewicz","year":"2006","journal-title":"Acc Chem Res"},{"issue":"38","key":"10.1016\/j.vaccine.2010.09.012_bib0360","doi-asserted-by":"crossref","first-page":"39671","DOI":"10.1074\/jbc.M402270200","article-title":"PrPSc binding antibodies are potent inhibitors of prion replication in cell lines","volume":"279","author":"Beringue","year":"2004","journal-title":"J Biol Chem"},{"issue":"16","key":"10.1016\/j.vaccine.2010.09.012_bib0365","doi-asserted-by":"crossref","first-page":"9295","DOI":"10.1073\/pnas.151242598","article-title":"Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody","volume":"98","author":"Enari","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6655","key":"10.1016\/j.vaccine.2010.09.012_bib0370","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/36337","article-title":"Prion (PrPSc)-specific epitope defined by a monoclonal antibody","volume":"390","author":"Korth","year":"1997","journal-title":"Nature"},{"issue":"6848","key":"10.1016\/j.vaccine.2010.09.012_bib0375","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35089090","article-title":"Antibodies inhibit prion propagation and clear cell cultures of prion infectivity","volume":"412","author":"Peretz","year":"2001","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.vaccine.2010.09.012_bib0380","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1471-4159.2004.02356.x","article-title":"Anti-PrP antibodies block PrPSc replication in prion-infected cell cultures by accelerating PrPC degradation","volume":"89","author":"Perrier","year":"2004","journal-title":"J Neurochem"},{"issue":"5540","key":"10.1016\/j.vaccine.2010.09.012_bib0385","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1126\/science.1063093","article-title":"Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies","volume":"294","author":"Heppner","year":"2001","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.vaccine.2010.09.012_bib0390","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/0092-8674(93)90360-3","article-title":"Mice devoid of PrP are resistant to scrapie","volume":"73","author":"Bueler","year":"1993","journal-title":"Cell"},{"issue":"5646","key":"10.1016\/j.vaccine.2010.09.012_bib0395","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.1090187","article-title":"Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis","volume":"302","author":"Mallucci","year":"2003","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.vaccine.2010.09.012_bib0400","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1073\/pnas.94.10.4931","article-title":"Scrapie susceptibility-linked polymorphisms modulate the in vitro conversion of sheep prion protein to protease-resistant forms","volume":"94","author":"Bossers","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Pt 13","key":"10.1016\/j.vaccine.2010.09.012_bib0405","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1242\/jcs.00494","article-title":"Specific inhibition of pathological prion protein accumulation by small interfering RNAs","volume":"116","author":"Daude","year":"2003","journal-title":"J Cell Sci"},{"issue":"12","key":"10.1016\/j.vaccine.2010.09.012_bib0410","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1172\/JCI29236","article-title":"Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice","volume":"116","author":"Pfeifer","year":"2006","journal-title":"J Clin Invest"},{"issue":"29","key":"10.1016\/j.vaccine.2010.09.012_bib0415","doi-asserted-by":"crossref","first-page":"10238","DOI":"10.1073\/pnas.0802759105","article-title":"Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease","volume":"105","author":"White","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"15","key":"10.1016\/j.vaccine.2010.09.012_bib0420","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.1073\/pnas.0401209101","article-title":"Silence of the genes","volume":"101","author":"Singer","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2010.09.012_bib0425","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.tibtech.2004.11.001","article-title":"Harnessing HIV for therapy, basic research and biotechnology","volume":"23","author":"Wiznerowicz","year":"2005","journal-title":"Trends Biotechnol"},{"issue":"11","key":"10.1016\/j.vaccine.2010.09.012_bib0430","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.1073\/pnas.110523897","article-title":"Interactions between heterologous forms of prion protein: binding, inhibition of conversion, and species barriers","volume":"97","author":"Horiuchi","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6333","key":"10.1016\/j.vaccine.2010.09.012_bib0435","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/352340a0","article-title":"Homozygous prion protein genotype predisposes to sporadic Creutzfeldt\u2013Jakob disease","volume":"352","author":"Palmer","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2010.09.012_bib0440","series-title":"Prion disease: susceptibility and transmissibility; in vivo and in vitro studies with sheep scrapie","author":"Bossers","year":"1999"},{"issue":"2","key":"10.1016\/j.vaccine.2010.09.012_bib0445","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1128\/JVI.72.2.1153-1159.1998","article-title":"Overexpression of nonconvertible PrPc delta114-121 in scrapie-infected mouse neuroblastoma cells leads to trans-dominant inhibition of wild-type PrP(Sc) accumulation","volume":"72","author":"Holscher","year":"1998","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2010.09.012_bib0450","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/jcp.2003.012203","article-title":"Resistance to scrapie in PrP ARR\/ARQ heterozygous sheep is not caused by preferential allelic use","volume":"57","author":"Caplazi","year":"2004","journal-title":"J Clin Pathol"},{"issue":"8","key":"10.1016\/j.vaccine.2010.09.012_bib0455","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3201\/eid1308.070077","article-title":"Classic scrapie in sheep with the ARR\/ARR prion genotype in Germany and France","volume":"13","author":"Groschup","year":"2007","journal-title":"Emerg Infect Dis"},{"issue":"44","key":"10.1016\/j.vaccine.2010.09.012_bib0460","doi-asserted-by":"crossref","first-page":"16031","DOI":"10.1073\/pnas.0502296102","article-title":"A newly identified type of scrapie agent can naturally infect sheep with resistant PrP genotypes","volume":"102","author":"Le Dur","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Pt 9","key":"10.1016\/j.vaccine.2010.09.012_bib0465","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1099\/vir.0.79997-0","article-title":"Neuronal accumulation of abnormal prion protein in sheep carrying a scrapie-resistant genotype (PrPARR\/ARR)","volume":"85","author":"Buschmann","year":"2004","journal-title":"J Gen Virol"},{"issue":"7019","key":"10.1016\/j.vaccine.2010.09.012_bib0470","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/432810a","article-title":"Transmissible spongiform encephalopathies: scrapie control under new strain","volume":"432","author":"Baylis","year":"2004","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.vaccine.2010.09.012_bib0475","doi-asserted-by":"crossref","first-page":"e2773","DOI":"10.1371\/journal.pone.0002773","article-title":"Effective gene therapy in a mouse model of prion diseases","volume":"3","author":"Toupet","year":"2008","journal-title":"PLoS ONE"},{"issue":"8","key":"10.1016\/j.vaccine.2010.09.012_bib0480","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1128\/JVI.73.8.6245-6250.1999","article-title":"Species-independent inhibition of abnormal prion protein (PrP) formation by a peptide containing a conserved PrP sequence","volume":"73","author":"Chabry","year":"1999","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2010.09.012_bib0485","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2567.2004.02074.x","article-title":"Follicular dendritic cell dedifferentiation reduces scrapie susceptibility following inoculation via the skin","volume":"114","author":"Mohan","year":"2005","journal-title":"Immunology"},{"issue":"6","key":"10.1016\/j.vaccine.2010.09.012_bib0490","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.4049\/jimmunol.178.6.3757","article-title":"Role of the GALT in scrapie agent neuroinvasion from the intestine","volume":"178","author":"Glaysher","year":"2007","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2010.09.012_bib0495","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1034\/j.1600-0463.2002.100104.x","article-title":"Early and late pathogenesis of natural scrapie infection in sheep","volume":"110","author":"van Keulen","year":"2002","journal-title":"Apmis"},{"issue":"9","key":"10.1016\/j.vaccine.2010.09.012_bib0500","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/nm0901-976","article-title":"Transepithelial prion transport by M cells","volume":"7","author":"Heppner","year":"2001","journal-title":"Nat Med"},{"issue":"50","key":"10.1016\/j.vaccine.2010.09.012_bib0505","doi-asserted-by":"crossref","first-page":"11280","DOI":"10.1523\/JNEUROSCI.2864-04.2004","article-title":"Protease-resistant human prion protein and ferritin are cotransported across Caco-2 epithelial cells: implications for species barrier in prion uptake from the intestine","volume":"24","author":"Mishra","year":"2004","journal-title":"J Neurosci"},{"issue":"11","key":"10.1016\/j.vaccine.2010.09.012_bib0510","doi-asserted-by":"crossref","first-page":"7758","DOI":"10.4049\/jimmunol.179.11.7758","article-title":"In vivo depletion of CD11c+ cells impairs scrapie agent neuroinvasion from the intestine","volume":"179","author":"Raymond","year":"2007","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2010.09.012_bib0515","doi-asserted-by":"crossref","first-page":"6845","DOI":"10.1128\/JVI.77.12.6845-6854.2003","article-title":"Follicular dendritic cell dedifferentiation by treatment with an inhibitor of the lymphotoxin pathway dramatically reduces scrapie susceptibility","volume":"77","author":"Mabbott","year":"2003","journal-title":"J Virol"},{"issue":"5469","key":"10.1016\/j.vaccine.2010.09.012_bib0520","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1126\/science.288.5469.1257","article-title":"Impaired prion replication in spleens of mice lacking functional follicular dendritic cells","volume":"288","author":"Montrasio","year":"2000","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.vaccine.2010.09.012_bib0525","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1128\/JVI.75.7.3453-3461.2001","article-title":"Branched polyamines cure prion-infected neuroblastoma cells","volume":"75","author":"Supattapone","year":"2001","journal-title":"J Virol"},{"issue":"Pt 6","key":"10.1016\/j.vaccine.2010.09.012_bib0530","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1099\/vir.0.19726-0","article-title":"Cationic phosphorus-containing dendrimers reduce prion replication both in cell culture and in mice infected with scrapie","volume":"85","author":"Solassol","year":"2004","journal-title":"J Gen Virol"},{"issue":"15","key":"10.1016\/j.vaccine.2010.09.012_bib0535","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1039\/B306682G","article-title":"Effects of beta-sheet breaker peptide polymers on scrapie-infected mouse neuroblastoma cells and their affinities to prion protein fragment PrP(81\u2013145)","volume":"1","author":"Oishi","year":"2003","journal-title":"Org Biomol Chem"},{"issue":"4","key":"10.1016\/j.vaccine.2010.09.012_bib0540","first-page":"319","article-title":"Beta-sheet breaker peptides reverse conformation of pathogenic prion proteins","volume":"247","author":"Reilly","year":"2000","journal-title":"J Neurol"},{"issue":"9199","key":"10.1016\/j.vaccine.2010.09.012_bib0545","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0140-6736(99)11419-3","article-title":"Reversion of prion protein conformational changes by synthetic beta-sheet breaker peptides","volume":"355","author":"Soto","year":"2000","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2010.09.012_bib0550","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1021\/bi00055a003","article-title":"Processing of a cellular prion protein: identification of N- and C-terminal cleavage sites","volume":"32","author":"Harris","year":"1993","journal-title":"Biochemistry"},{"issue":"10","key":"10.1016\/j.vaccine.2010.09.012_bib0555","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/pro.5560011014","article-title":"Purification and properties of the cellular prion protein from Syrian hamster brain","volume":"1","author":"Pan","year":"1992","journal-title":"Protein Sci"},{"issue":"1","key":"10.1016\/j.vaccine.2010.09.012_bib0560","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1083\/jcb.129.1.121","article-title":"Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform","volume":"129","author":"Taraboulos","year":"1995","journal-title":"J Cell Biol"},{"issue":"21","key":"10.1016\/j.vaccine.2010.09.012_bib0565","doi-asserted-by":"crossref","first-page":"21948","DOI":"10.1074\/jbc.M400793200","article-title":"Calpain-dependent endoproteolytic cleavage of PrPSc modulates scrapie prion propagation","volume":"279","author":"Yadavalli","year":"2004","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.vaccine.2010.09.012_bib0570","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1074\/jbc.M410649200","article-title":"Calpain and other cytosolic proteases can contribute to the degradation of retro-translocated prion protein in the cytosol","volume":"280","author":"Wang","year":"2005","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.vaccine.2010.09.012_bib0575","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1212\/WNL.43.11.2335","article-title":"Scrapie prions alter receptor-mediated calcium responses in cultured cells","volume":"43","author":"Kristensson","year":"1993","journal-title":"Neurology"},{"issue":"47","key":"10.1016\/j.vaccine.2010.09.012_bib0580","doi-asserted-by":"crossref","first-page":"43516","DOI":"10.1074\/jbc.M103894200","article-title":"Prion protein fragment PrP-(106-126) induces apoptosis via mitochondrial disruption in human neuronal SH-SY5Y cells","volume":"276","author":"O\u2019Donovan","year":"2001","journal-title":"J Biol Chem"},{"issue":"18","key":"10.1016\/j.vaccine.2010.09.012_bib0585","doi-asserted-by":"crossref","first-page":"6617","DOI":"10.1073\/pnas.85.18.6617","article-title":"Immunoaffinity purification and neutralization of scrapie prion infectivity","volume":"85","author":"Gabizon","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"10.1016\/j.vaccine.2010.09.012_bib0590","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1093\/emboj\/18.12.3193","article-title":"Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state","volume":"18","author":"Horiuchi","year":"1999","journal-title":"EMBO J"},{"issue":"1","key":"10.1016\/j.vaccine.2010.09.012_bib0595","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0002-9440(10)64151-X","article-title":"Immunization delays the onset of prion disease in mice","volume":"161","author":"Sigurdsson","year":"2002","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.vaccine.2010.09.012_bib0600","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0304-3940(02)01192-8","article-title":"Anti-prion antibodies for prophylaxis following prion exposure in mice","volume":"336","author":"Sigurdsson","year":"2003","journal-title":"Neurosci Lett"},{"issue":"3","key":"10.1016\/j.vaccine.2010.09.012_bib0605","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0304-3940(03)00907-8","article-title":"Immunisation with a synthetic prion protein-derived peptide prolongs survival times of mice orally exposed to the scrapie agent","volume":"350","author":"Schwarz","year":"2003","journal-title":"Neurosci Lett"},{"issue":"7","key":"10.1016\/j.vaccine.2010.09.012_bib0610","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1128\/JVI.79.7.4033-4042.2005","article-title":"Circumventing tolerance to the prion protein (PrP): vaccination with PrP-displaying retrovirus particles induces humoral immune responses against the native form of cellular PrP","volume":"79","author":"Nikles","year":"2005","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2010.09.012_bib0615","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1111\/j.1742-4658.2007.05721.x","article-title":"Vaccination with prion peptide-displaying papillomavirus-like particles induces autoantibodies to normal prion protein that interfere with pathologic prion protein production in infected cells","volume":"274","author":"Handisurya","year":"2007","journal-title":"FEBS J"},{"issue":"6927","key":"10.1016\/j.vaccine.2010.09.012_bib0620","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/nature01457","article-title":"Monoclonal antibodies inhibit prion replication and delay the development of prion disease","volume":"422","author":"White","year":"2003","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.vaccine.2010.09.012_bib0625","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.molmed.2008.07.004","article-title":"The potential of intracellular antibodies for therapeutic targeting of protein-misfolding diseases","volume":"14","author":"Cardinale","year":"2008","journal-title":"Trends Mol Med"},{"issue":"5663","key":"10.1016\/j.vaccine.2010.09.012_bib0630","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1126\/science.1094273","article-title":"Cross-linking cellular prion protein triggers neuronal apoptosis in vivo","volume":"303","author":"Solforosi","year":"2004","journal-title":"Science"},{"issue":"Pt 3","key":"10.1016\/j.vaccine.2010.09.012_bib0635","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1099\/0022-1317-67-3-463","article-title":"Prolongation of scrapie incubation period by an injection of dextran sulphate 500 within the month before or after infection","volume":"67","author":"Farquhar","year":"1986","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2010.09.012_bib0640","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1128\/JVI.67.2.643-650.1993","article-title":"Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells","volume":"67","author":"Caughey","year":"1993","journal-title":"J Virol"},{"issue":"Pt 9","key":"10.1016\/j.vaccine.2010.09.012_bib0645","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1099\/vir.0.19073-0","article-title":"A novel generation of heparan sulfate mimetics for the treatment of prion diseases","volume":"84","author":"Adjou","year":"2003","journal-title":"J Gen Virol"},{"issue":"Pt 3","key":"10.1016\/j.vaccine.2010.09.012_bib0650","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1099\/vir.0.82286-0","article-title":"Comparison of CR36, a new heparan mimetic, and pentosan polysulfate in the treatment of prion diseases","volume":"88","author":"Larramendy-Gozalo","year":"2007","journal-title":"J Gen Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2010.09.012_bib0655","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jinf.2004.07.015","article-title":"Cerebroventricular infusion of pentosan polysulphate in human variant Creutzfeldt\u2013Jakob disease","volume":"50","author":"Todd","year":"2005","journal-title":"J Infect"},{"issue":"6","key":"10.1016\/j.vaccine.2010.09.012_bib0660","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00701-006-0772-y","article-title":"Unsuccessful intraventricular pentosan polysulphate treatment of variant Creutzfeldt\u2013Jakob disease","volume":"148","author":"Whittle","year":"2006","journal-title":"Acta Neurochir (Wien)"},{"issue":"5","key":"10.1016\/j.vaccine.2010.09.012_bib0665","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1468-1331.2008.02108.x","article-title":"Intraventricular pentosan polysulphate in human prion diseases: an observational study in the UK","volume":"15","author":"Bone","year":"2008","journal-title":"Eur J Neurol"},{"issue":"5","key":"10.1016\/j.vaccine.2010.09.012_bib0670","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1468-1331.2008.02109.x","article-title":"Creutzfeldt\u2013Jakob disease: hopes for therapy","volume":"15","author":"Pocchiari","year":"2008","journal-title":"Eur J Neurol"},{"issue":"7","key":"10.1016\/j.vaccine.2010.09.012_bib0675","first-page":"406","article-title":"Evaluation of anti-prion activity of congo red and its derivatives in experimentally infected hamsters","volume":"54","author":"Poli","year":"2004","journal-title":"Arzneimittelforschung"},{"issue":"2","key":"10.1016\/j.vaccine.2010.09.012_bib0680","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1471-4159.1992.tb09437.x","article-title":"Potent inhibition of scrapie-associated PrP accumulation by congo red","volume":"59","author":"Caughey","year":"1992","journal-title":"J Neurochem"},{"issue":"22","key":"10.1016\/j.vaccine.2010.09.012_bib0685","doi-asserted-by":"crossref","first-page":"5515","DOI":"10.1021\/jm049922t","article-title":"Synthesis of analogues of Congo red and evaluation of their anti-prion activity","volume":"47","author":"Sellarajah","year":"2004","journal-title":"J Med Chem"},{"issue":"9","key":"10.1016\/j.vaccine.2010.09.012_bib0690","doi-asserted-by":"crossref","first-page":"5499","DOI":"10.1128\/JVI.77.9.5499-5502.2003","article-title":"Inhibition of protease-resistant prion protein accumulation in vitro by curcumin","volume":"77","author":"Caughey","year":"2003","journal-title":"J Virol"},{"issue":"Pt 2","key":"10.1016\/j.vaccine.2010.09.012_bib0695","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1099\/vir.0.83281-0","article-title":"Evaluation of drugs for treatment of prion infections of the central nervous system","volume":"89","author":"Riemer","year":"2008","journal-title":"J Gen Virol"},{"issue":"21","key":"10.1016\/j.vaccine.2010.09.012_bib0700","doi-asserted-by":"crossref","first-page":"12117","DOI":"10.1073\/pnas.95.21.12117","article-title":"Inhibition of protease-resistant prion protein formation by porphyrins and phthalocyanines","volume":"95","author":"Caughey","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5457","key":"10.1016\/j.vaccine.2010.09.012_bib0705","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1126\/science.287.5457.1503","article-title":"Porphyrin and phthalocyanine antiscrapie compounds","volume":"287","author":"Priola","year":"2000","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.vaccine.2010.09.012_bib0710","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1086\/377310","article-title":"Prophylactic and therapeutic effects of phthalocyanine tetrasulfonate in scrapie-infected mice","volume":"188","author":"Priola","year":"2003","journal-title":"J Infect Dis"},{"issue":"15","key":"10.1016\/j.vaccine.2010.09.012_bib0715","doi-asserted-by":"crossref","first-page":"8462","DOI":"10.1128\/JVI.77.15.8462-8469.2003","article-title":"Evaluation of quinacrine treatment for prion diseases","volume":"77","author":"Barret","year":"2003","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2010.09.012_bib0720","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1128\/JVI.74.10.4894-4897.2000","article-title":"Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation","volume":"74","author":"Doh-Ura","year":"2000","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2010.09.012_bib0725","doi-asserted-by":"crossref","first-page":"4999","DOI":"10.1128\/JVI.78.10.4999-5006.2004","article-title":"Treatment of transmissible spongiform encephalopathy by intraventricular drug infusion in animal models","volume":"78","author":"Doh-ura","year":"2004","journal-title":"J Virol"},{"issue":"17","key":"10.1016\/j.vaccine.2010.09.012_bib0730","doi-asserted-by":"crossref","first-page":"9836","DOI":"10.1073\/pnas.161274798","article-title":"Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease","volume":"98","author":"Korth","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.vaccine.2010.09.012_bib0735","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1128\/JVI.78.3.1281-1288.2004","article-title":"Quinoline derivatives are therapeutic candidates for transmissible spongiform encephalopathies","volume":"78","author":"Murakami-Kubo","year":"2004","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2010.09.012_bib0740","first-page":"403","article-title":"Quinacrine administration to a patient with Creutzfeldt\u2013Jakob disease who received a cadaveric dura mater graft\u2014an EEG evaluation","volume":"43","author":"Kobayashi","year":"2003","journal-title":"Rinsho Shinkeigaku"},{"issue":"3","key":"10.1016\/j.vaccine.2010.09.012_bib0745","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000076350","article-title":"Results of quinacrine administration to patients with Creutzfeldt\u2013Jakob disease","volume":"17","author":"Nakajima","year":"2004","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"6","key":"10.1016\/j.vaccine.2010.09.012_bib0750","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.surneu.2005.03.035","article-title":"Creutzfeldt\u2013Jakob disease acquired via a dural graft: failure of therapy with quinacrine and chlorpromazine","volume":"64","author":"Martinez-Lage","year":"2005","journal-title":"Surg Neurol"},{"issue":"9552","key":"10.1016\/j.vaccine.2010.09.012_bib0755","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/S0140-6736(06)69835-8","article-title":"Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt\u2013Jakob disease associated with blood transfusion: a case report","volume":"368","author":"Wroe","year":"2006","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2010.09.012_bib0760","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s10571-004-6926-7","article-title":"Toxicity of quinacrine can be reduced by co-administration of P-glycoprotein inhibitor in sporadic Creutzfeldt\u2013Jakob disease","volume":"24","author":"Satoh","year":"2004","journal-title":"Cell Mol Neurobiol"},{"issue":"4","key":"10.1016\/j.vaccine.2010.09.012_bib0765","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ana.10530","article-title":"Quinacrine-induced cytolytic hepatitis in sporadic Creutzfeldt\u2013Jakob disease","volume":"53","author":"Scoazec","year":"2003","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.vaccine.2010.09.012_bib0770","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/1871526510909010023","article-title":"Tetracyclines and prion infectivity","volume":"9","author":"Forloni","year":"2009","journal-title":"Infect Disord Drug Targets"},{"issue":"4","key":"10.1016\/j.vaccine.2010.09.012_bib0775","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0002-9440(10)61192-3","article-title":"Bovine prion is endocytosed by human enterocytes via the 37kDa\/67kDa laminin receptor","volume":"167","author":"Morel","year":"2005","journal-title":"Am J Pathol"},{"issue":"17","key":"10.1016\/j.vaccine.2010.09.012_bib0780","doi-asserted-by":"crossref","first-page":"17062","DOI":"10.1074\/jbc.M500122200","article-title":"Heparan sulfate is a cellular receptor for purified infectious prions","volume":"280","author":"Horonchik","year":"2005","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.vaccine.2010.09.012_bib0785","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1083\/jcb.125.6.1239","article-title":"A glycolipid-anchored prion protein is endocytosed via clathrin-coated pits","volume":"125","author":"Shyng","year":"1994","journal-title":"J Cell Biol"},{"issue":"5486","key":"10.1016\/j.vaccine.2010.09.012_bib0790","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1126\/science.289.5486.1925","article-title":"Signal transduction through prion protein","volume":"289","author":"Mouillet-Richard","year":"2000","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.vaccine.2010.09.012_bib0795","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1074\/jbc.M406199200","article-title":"Modulation of serotonergic receptor signaling and cross-talk by prion protein","volume":"280","author":"Mouillet-Richard","year":"2005","journal-title":"J Biol Chem"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2010.09.012_bib0800","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1023\/A:1020244621373","article-title":"Association of cellular prion protein with gangliosides in plasma membrane microdomains of neural and lymphocytic cells","volume":"27","author":"Mattei","year":"2002","journal-title":"Neurochem Res"},{"issue":"11","key":"10.1016\/j.vaccine.2010.09.012_bib0805","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1111\/j.1460-9568.2006.05156.x","article-title":"The interaction between prion protein and laminin modulates memory consolidation","volume":"24","author":"Coitinho","year":"2006","journal-title":"Eur J Neurosci"},{"issue":"1","key":"10.1016\/j.vaccine.2010.09.012_bib0810","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bbrc.2004.12.132","article-title":"PrP cooperates with STI1 to regulate SOD activity in PrP-deficient neuronal cell line","volume":"328","author":"Sakudo","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.vaccine.2010.09.012_bib0815","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0006-291X(03)00805-2","article-title":"Efficient and specific down-regulation of prion protein expression by RNAi","volume":"305","author":"Tilly","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"10.1016\/j.vaccine.2010.09.012_bib0820","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1128\/JVI.68.8.4873-4878.1994","article-title":"Heterologous PrP molecules interfere with accumulation of protease-resistant PrP in scrapie-infected murine neuroblastoma cells","volume":"68","author":"Priola","year":"1994","journal-title":"J Virol"},{"issue":"21","key":"10.1016\/j.vaccine.2010.09.012_bib0825","doi-asserted-by":"crossref","first-page":"13203","DOI":"10.1074\/jbc.273.21.13203","article-title":"Specific inhibition of in vitro formation of protease-resistant prion protein by synthetic peptides","volume":"273","author":"Chabry","year":"1998","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.vaccine.2010.09.012_bib0830","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/77401","article-title":"Temporary inactivation of follicular dendritic cells delays neuroinvasion of scrapie","volume":"6","author":"Mabbott","year":"2000","journal-title":"Nat Med"},{"issue":"Pt 8","key":"10.1016\/j.vaccine.2010.09.012_bib0835","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1099\/0022-1317-65-8-1325","article-title":"Dextran sulphate 500 delays and prevents mouse scrapie by impairment of agent replication in spleen","volume":"65","author":"Ehlers","year":"1984","journal-title":"J Gen Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2010.09.012_bib0840","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1128\/AAC.30.3.409","article-title":"Suppression of scrapie infection in mice by heteropolyanion 23, dextran sulfate, and some other polyanions","volume":"30","author":"Kimberlin","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"issue":"15","key":"10.1016\/j.vaccine.2010.09.012_bib0845","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1093\/emboj\/20.15.3957","article-title":"Intracellular re-routing of prion protein prevents propagation of PrP(Sc) and delays onset of prion disease","volume":"20","author":"Gilch","year":"2001","journal-title":"EMBO J"},{"issue":"Pt 21","key":"10.1016\/j.vaccine.2010.09.012_bib0850","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.1242\/jcs.02609","article-title":"Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication","volume":"118","author":"Nunziante","year":"2005","journal-title":"J Cell Sci"},{"issue":"11","key":"10.1016\/j.vaccine.2010.09.012_bib0855","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1128\/AAC.01599-06","article-title":"Cyclic tetrapyrrole sulfonation, metals, and oligomerization in antiprion activity","volume":"51","author":"Caughey","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.vaccine.2010.09.012_bib0860","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/ana.10336","article-title":"Quinacrine does not prolong survival in a murine Creutzfeldt\u2013Jakob disease model","volume":"52","author":"Collins","year":"2002","journal-title":"Ann Neurol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10013204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10013204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T15:36:33Z","timestamp":1591976193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10013204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":172,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0264410X10013204"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.09.012","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}